Regulations.gov document
2024-000841 - Natrol LLC - Natrol® 5-HTP 100mg Capsules- Promotes production of serotonin
Other · FDA-2024-S-0024 · posted Jun 11, 2024
Key facts
| Document ID | FDA-2024-S-0024-0235 |
|---|---|
| Title | 2024-000841 - Natrol LLC - Natrol® 5-HTP 100mg Capsules- Promotes production of serotonin |
| Document type | Other |
| Subtype | 30 Day Structured Function Claim |
| Agency | FDA |
| Docket | FDA-2024-S-0024 |
| Posted | Jun 11, 2024 |
| Comment period opens | Jun 11, 2024 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: